Prazer Therapeutics headquarters details
- Street address
- 117-3 Hoegi-Ro Dongdaemun-Gu Seoul
- State / region
- Seoul
- ZIP / postal code
- 05836
- Country
- South Korea
- Phone
- +82 2 6217 1020
- Founded
- 2019
- Website
- prazertx.com
- linkedin.com/company/prazertx
Location map
Open in Google MapsAll Prazer Therapeutics office locations
| City | State / region | Country | Type |
|---|---|---|---|
| — HQ | Seoul | South Korea | Headquarters |
Showing the headquarters of 3 recorded locations. See every location in GraphIQ →
About Prazer Therapeutics
Prazer Therapeutics is headquartered in Seoul, South Korea. Founded in 2019, the company has 3 recorded locations and employs approximately 18 people worldwide.
Prazer Therapeutics contact information
The main switchboard for Prazer Therapeutics headquarters can be reached at +82 2 6217 1020. Official website: prazertx.com.
What does Prazer Therapeutics do?
Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
Frequently asked questions
Where is Prazer Therapeutics headquarters?
Prazer Therapeutics's headquarters is located at 117-3 Hoegi-Ro Dongdaemun-Gu Seoul, Seoul 05836, South Korea.
How many offices does Prazer Therapeutics have?
GraphIQ records 3 locations for Prazer Therapeutics, as of October 2026.
What is Prazer Therapeutics's corporate address?
The corporate headquarters address is 117-3 Hoegi-Ro Dongdaemun-Gu Seoul, Seoul 05836, South Korea.
When was Prazer Therapeutics founded?
Prazer Therapeutics was founded in 2019 and employs approximately 18 people.
What is Prazer Therapeutics's phone number?
The main phone number for Prazer Therapeutics headquarters is +82 2 6217 1020.
How many employees does Prazer Therapeutics have?
Prazer Therapeutics has approximately 18 employees (GraphIQ estimate, 2026).